Clinical trial
Steroid Treatment for Kidney Disease
NCT00065611 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00065611 |
|---|---|
| Title | Steroid Treatment for Kidney Disease |
| Official title | Pulse Dexamethasone Over 48 Weeks for Podocyte Disease |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nephrosis, Focal Lipoid Glomerulosclerosis |
| Intervention type | Drug |
| Interventions | Oral dexamethasone |
| Enrollment | 8 |
| Start date | Jul 1, 2003 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Jul 29, 2003 |
| Last update posted | Oct 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: